These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 33107700)
21. Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer. Xia J; Luo M; Dai L; Wang L; Wang L; Zhu J J Clin Lab Anal; 2021 May; 35(5):e23743. PubMed ID: 33682961 [TBL] [Abstract][Full Text] [Related]
22. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer. Zheng B; Peng M; Gong J; Li C; Cheng H; Li Y; Tang Y Exp Biol Med (Maywood); 2023 Aug; 248(16):1403-1413. PubMed ID: 37551102 [TBL] [Abstract][Full Text] [Related]
23. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer. Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113 [TBL] [Abstract][Full Text] [Related]
24. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid exosomal microRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases. Li H; Xia M; Zheng S; Lin Y; Yu T; Xie Y; Shen Y; Liu X; Qian X; Yin Z Biotechnol Genet Eng Rev; 2024 Apr; 40(1):359-380. PubMed ID: 36852928 [TBL] [Abstract][Full Text] [Related]
26. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4. Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570 [TBL] [Abstract][Full Text] [Related]
27. microRNA-let-7e in serum-derived exosomes inhibits the metastasis of non-small-cell lung cancer in a SUV39H2/LSD1/CDH1-dependent manner. Xu S; Zheng L; Kang L; Xu H; Gao L Cancer Gene Ther; 2021 Apr; 28(3-4):250-264. PubMed ID: 33299140 [TBL] [Abstract][Full Text] [Related]
29. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555 [TBL] [Abstract][Full Text] [Related]
30. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2. Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230 [TBL] [Abstract][Full Text] [Related]
31. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1. Shang A; Wang X; Gu C; Liu W; Sun J; Zeng B; Chen C; Ji P; Wu J; Quan W; Yao Y; Wang W; Sun Z; Li D Aging (Albany NY); 2020 May; 12(9):8352-8371. PubMed ID: 32364530 [TBL] [Abstract][Full Text] [Related]
32. Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs. Hassanin AAI; Ramos KS Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409003 [TBL] [Abstract][Full Text] [Related]
33. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma. Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597 [TBL] [Abstract][Full Text] [Related]
34. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer. Zhang ZJ; Song XG; Xie L; Wang KY; Tang YY; Yu M; Feng XD; Song XR Exp Biol Med (Maywood); 2020 Oct; 245(16):1428-1436. PubMed ID: 32741216 [TBL] [Abstract][Full Text] [Related]
35. miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study. Ĺwitlik W; Karbownik MS; Suwalski M; Kozak J; Szemraj J Cancer Biomark; 2018 Feb; 21(2):479-488. PubMed ID: 29103030 [TBL] [Abstract][Full Text] [Related]
36. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
37. MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition. Zhang L; Quan H; Wang S; Li X; Che X Tumour Biol; 2015 Sep; 36(10):8121-6. PubMed ID: 25983004 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
39. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer. Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319 [TBL] [Abstract][Full Text] [Related]
40. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]